Pharmaceutical Technology-03-01-2012

Pharmaceutical Technology

Pharmaceutical Technology March 2012 Solid Dosage Supplement (PDF)

March 01, 2012

Issue PDF

2012 Supplement

2

Solid Dosage and Excipients

The American National Standard for Excipient GMP

March 01, 2012

Articles

2012 Supplement

2

The author reviews significant changes to GMP for excipients in the forthcoming American National Standard, including a risk-based approach to excipient manufacture, why new requirements were proposed, and their potential impact to excipient manufacturers.

Powder Testing Techniques for Tablet Manufacture

March 01, 2012

Articles

2012 Supplement

2

This article considers the different conditions to which the powder is subjected in the tableting process, and discusses which powder properties should be measured to accurately reflect likely powder behavior in the process.

Meeting Solubility Challenges

March 01, 2012

Articles

2012 Supplement

2

Pharmaceutical companies, equipment providers, contract-service providers, and excipient manufacturers apply various approaches for improving solubility. The article examines some recent developments.

Physical-Chemical Identifiers: A Q&A with FDA on the Final Guidance

March 01, 2012

Articles

2012 Supplement

2

FDA answers key questions about the October 2011 guidance on using physical–chemical identifiers in solid oral dosage products to help prevent and avoid counterfeiting.